Key result
A mobile health application with financial incentives did not improve median medication adherence at 90 days compared to standard care in patients with hypertension.
Why the study?
Non-adherence to antihypertensive therapy remains a major barrier to optimal blood pressure control.
Does a behavioral economics-based mobile health application with or without financial incentives improve medication adherence and blood pressure in outpatients with hypertension?
RCT (n=219)
Open-label
1:1:1 centralized eCRF-based block randomization stratified by gender
Yes
Does a behavioral economics-based mobile health application with or without financial incentives improve medication adherence and blood pressure in outpatients with hypertension?
Answers are grounded in this paper and cite their sources.
A multifaceted mobile app with or without financial incentives did not improve medication adherence or blood pressure in a hypertensive population that already had high baseline adherence and well-controlled blood pressure.
Background: Non-adherence to antihypertensive therapy remains a major barrier to optimal blood pressure (BP) control. This study evaluated whether a multi-faceted medication adherence mobile application (mApp), with or without financial incentives (FI), improves adherence and BP compared with standard care. Methods: In this multicenter, randomized, open-label trial, outpatients with hypertension taking ≥4 pills/day were randomized to (A) mApp with FI, (B) mApp without FI, or (C) standard-of-care. Adherence was measured by Medication Event Monitoring System (MEMS) dispensers. Primary endpoint was median adherence at 90 days comparing A with C; the co-primary endpoint compared adherence during month 3 versus month 1. Secondary outcomes included self-reported adherence, office and ambulatory BP over 90 and 180 days. Results: Of 219 randomized participants, 176 (80.4%) completed the 90-day visit (median age 63 years; 23% women). Median adherence at 90 days was 95.6% in A and C (p=0.551). Median change in adherence from month 1 to month 3 was 0% in A and 1.6% in C (p=0.691). No significant differences were observed for BP. Self-reported adherence did not differ between groups, although within-group analyses showed improvement over time in A (p=0.001). Conclusions: In outpatients with hypertension and unexpectedly high observed adherence and no substantial BP elevation at baseline, neither the mApp nor FI improved MEMS-measured adherence or BP. Future interventions should focus on identifying and engaging patients with low medication adherence and sufficient room for BP improvement, for whom digital strategies may have greater impact.
No takes yet. Share an insight, caveat, or question.
Strebel et al. (2026) conducted an RCT in Hypertension (n=219). Mobile health application (mApp) with financial incentives vs. Standard-of-care was evaluated on Median medication adherence at 90 days measured by Medication Event Monitoring System (MEMS) (p=0.551). A mobile health application with financial incentives did not improve median medication adherence at 90 days compared to standard care in patients with hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: